Advanced Medical Solutions Group PLC (GB:AMS)
LSE:AMS
Total Valuation
Advanced Medical Solutions has a market cap or net worth of £426.75M. The enterprise value is 490.23M .
Market Cap£426.75M
Enterprise Value490.23M
Share Statistics
Advanced Medical Solutions has 219,604,170 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding219,604,170
Owned by Insiders1.08%
Owned by Institutions―
Financial Efficiency
Advanced Medical Solutions’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 3.47%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)3.47%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee152.62K
Profits Per Employee6.64K
Employee Count1,500
Asset Turnover0.58
Inventory Turnover1.72
Valuation Ratios
The current PE Ratio of Advanced Medical Solutions is 47.2. Advanced Medical Solutions’s PEG ratio is 1.19.
PE Ratio47.2
PS Ratio2.05
PB Ratio1.82
Price to Fair Value1.82
Price to FCF21.97
Price to Operating Cash Flow13.74
PEG Ratio1.19
Income Statement
In the last 12 months, Advanced Medical Solutions had revenue of 228.94M and earned 9.95M in profits. Earnings per share was 0.05.
Revenue228.94M
Gross Profit108.78M
Operating Income21.99M
Pretax Income17.78M
Net Income9.95M
EBITDA43.39M
Earnings Per Share (EPS)0.05
Cash Flow
In the last 12 months, operating cash flow was 31.10M and capital expenditures -7.36M, giving a free cash flow of 23.75M billion.
Operating Cash Flow31.10M
Free Cash Flow23.75M
Free Cash Flow per Share0.11
Dividends & Yields
Advanced Medical Solutions pays an annual dividend of 0.85 p, resulting in a dividend yield of 1.25%
Dividend Per Share0.85 p
Dividend Yield1.25%
Payout Ratio37.75%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.34
52-Week Price Change12.20%
50-Day Moving Average206.24
200-Day Moving Average210.94
Relative Strength Index (RSI)47.59
Average Volume (3m)800.99K
Important Dates
Advanced Medical Solutions upcoming earnings date is Sep 23, 2026, TBA (Confirmed).
Last Earnings DateMar 18, 2026
Next Earnings DateSep 23, 2026
Ex-Dividend Date―
Financial Position
Advanced Medical Solutions as a current ratio of 2.79, with Debt / Equity ratio of 31.50%
Current Ratio2.79
Quick Ratio1.39
Debt to Market Cap0.15
Net Debt to EBITDA1.46
Interest Coverage Ratio4.32
Taxes
In the past 12 months, Advanced Medical Solutions has paid 7.69M in taxes.
Income Tax7.69M
Effective Tax Rate0.43
Enterprise Valuation
Advanced Medical Solutions EV to EBITDA ratio is 12.29, with an EV/FCF ratio of 24.94.
EV to Sales2.33
EV to EBITDA12.29
EV to Free Cash Flow24.94
EV to Operating Cash Flow18.55
Balance Sheet
Advanced Medical Solutions has £18.02M in cash and marketable securities with £81.52M in debt, giving a net cash position of -£63.51M billion.
Cash & Marketable Securities£18.02M
Total Debt£81.52M
Net Cash-£63.51M
Net Cash Per Share-£0.29
Tangible Book Value Per Share£1.21
Margins
Gross margin is 50.47%, with operating margin of 9.61%, and net profit margin of 4.35%.
Gross Margin50.47%
Operating Margin9.61%
Pretax Margin7.77%
Net Profit Margin4.35%
EBITDA Margin18.95%
EBIT Margin9.61%
Analyst Forecast
The average price target for Advanced Medical Solutions is £300.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target£300.00
Price Target Upside39.53% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast68.03%
EPS Growth Forecast-18.27%